Omega Healthcare Investors: Barclays cuts target price to $48 from $50
OHI•Barclays cut its target price for Omega Healthcare Investors to $48 from $50.
Related News
Beam Therapeutics reports initial Phase 1/2 data for BEAM-301 in glycogen storage disease type Ia trial
BEAM•
Entain BetMGM Q3 2026 net revenue up 7% to $710 million
MGM•
Occidental Petroleum says production partially restored at Gulf of America facilities
OXY•
Upbound Group sets third-quarter financial results release, conference call timing
UPBD•
IQVIA expands partnership with Veeva, adopts its clinical operations applications across trials
IQV•